MyRACentral.com

See all of our health sites at www.HealthCentral.com
Sunday, July, 20, 2008

Christine Miller's SharePosts Relating to: "Journal Entry"

Mortality Gap Between RA Patients and the General Population is Widening

In the past five decades, the country overall has seen an upward trend in people living longer. But it seems that for all the advances in Rheumatoid Arthritis drugs and treatments, there have been no improvements in lifespan for people with RA. New research published in the journal Arthritis & Rheumatism has found that despite much... Read moreChevron

Add comment  |  No Comments

TNF inhibitors may slightly increase risk for skin cancer

Tumor necrosis factor inhibitors such as etanercept (Enbrel) or infliximab (Remicade) are some of the newest and most expensive drugs available to treat rheumatoid arthritis. Because they are so effective for many people with RA, the numbers of people taking them has been growing significantly over the last few years, despite the very high cost of... Read moreChevron

Rheumatologists Overestimate Physical Disability in Their Patients

Rheumatologists are frequently required to evaluate the functional disability of their patients for employers, disability attorneys, insurance companies and government agencies. The evaluations are used to determine eligibility for disability payments, employment accommodations, or for certificates of need for durable medical equipment and... Read moreChevron

Add comment  |  No Comments

Another Reason Why Stress is Bad for Us

Last year, I wrote about research finding links between stress and depression and increased rheumatoid arthritis disease activity. Now, new research presented this month at the annual convention of the American Psychological Association shows that chronic stress can exacerbate inflammation and increases a person's risk of developing autoimmune... Read moreChevron

Add comment  |  No Comments

Hydroxychloroquine May Reduce Risk of Type 2 Diabetes

Researchers have found a link between hydroxychloroquine and a decreased risk of developing type-2 diabetes. Hydroxychloroquine has been in use for approximately 50 years. It was first developed as an anti-malaria drug, and then as treatment for rheumatoid arthritis, lupus and other rheumatic diseases.  In type-2 diabetes, the formerly... Read moreChevron

Ask a Question

Get answers from our experts and community members.

Answer a Question

Alcohol comsumption and Rheumatoid Arthritis

Answer This View all questions >
Healthcare 08